Amrize Ltd
NYSE:AMRZConstruction Materials
+$1.05 today
- Market cap
- $22.10B
- Beta
- -0.09
Volume 3.68M
Average 3.11M
AMRZ Total Current Liabilities
All obligations due within one year.
Amrize LtdNYSE: AMRZ
Total Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total current liabilities rises 32.2% from a year ago
Total current liabilities stood at $4.15B at the end of Q2 FY2026, up 32.2% from a year earlier and up 36.0% from the prior quarter. Over 3 fiscal years it compounded at +8.3% a year.
Context
- Total current liabilities amounted to 16.9% of total assets at the end of Q2 FY2026, up 3.7 pp from a year earlier.
- Total current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +32.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 2.86B USD
- Year-over-year change
- +17.6%
- 3-year CAGR
- +8.3%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.86B | +17.6% |
| FY2024 | 2024-12-31 | 2.43B | -0.5% |
| FY2023 | 2023-12-31 | 2.44B | +8.5% |
| FY2022 | 2022-12-31 | 2.25B | — |
Total Current Liabilities vs competitors
How AMRZ compares with its peers on the latest reported figures
- AMRZ's Jun 2026 total current liabilities of $4.15B is the 2nd highest of the 7 companies compared; the peer median is $1.49B.
- Its year-over-year change of +32.2% is the 2nd highest of 7, against a peer median of +15.1%.
- Total current liabilities amounts to 16.9% of total assets for AMRZ, versus a peer median of 11.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $9.98B | +14.9% | -0.5% | 17.0% | |
AMRZAmrize Ltd | Jun 2026 | $4.15B | +32.2% | +8.3% | 16.9% |
| Jun 2026 | $2.97B | +15.3% | +8.1% | 23.3% | |
| Jun 2026 | $1.74B | +70.7% | -14.8% | 8.2% | |
| Jun 2026 | $1.23B | -8.2% | -0.0% | 7.5% | |
| Jun 2026 | $883.4M | +26.7% | -12.0% | 14.2% | |
| Jun 2026 | $287.6M | +7.2% | +6.9% | 7.4% | |
| Peer median (excluding AMRZ) | $1.49B | +15.1% | -0.3% | 11.2% | |
Competitors are the stored peer set for AMRZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Amrize Ltd
NYSE:AMRZ
Intrinsic Alpha fair value
Locked
Current Price
$40.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.